Source: International Congress 2015 – Screening strategies in TB
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
James Clemence (London, United Kingdom), James Clemence, Hugo Farne, Harriet Owles, James Wilson, Dean Creer, Douglas Fink. Low real-world utility of IGRA when screening for LTBI in a low incidence setting. Eur Respir J 2015; 46: Suppl. 59, 2978

Member's Comments

No comment yet.

Related content which might interest you: Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Safety of two step tuberculin skin test (TST) in the screening of healthcare workers for latent TB infection (LTBI) Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 The changing indications for IGRA testing and impact on TB services in a UK district general hospital Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Latent tuberculosis among health care workers in Denmark estimated by IGRA Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands Source: International Congress 2015 – Latent TB infection and screening Year: 2015 Increased incidence of TB disease within the health-care workers in an intermediate TB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Knowledge and attitude about tuberculosis disease in a health workers population Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Latent TB infection in health care TB workers Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Do we need to screen for latent TB when initiating a methotrexate treatment? Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013